Home
Domes Pharma Group

Domes Pharma Group Market Share Analysis for February 2026

Pets and Animals > Pet Food and Supplies

Domaindomespharma.com

Year Founded1947

Employees201 - 500

Annual Revenue$75M - $100M

Domes Pharma Group

Domes Pharma Group (including company regionals)

domespharma.com

See more website traffic and engagement information

Domes Pharma Group Revenue up to February 2026 is 75M - 100M

revenue generated by Domes Pharma Group top domains

Domes Pharma Group top domains revenue over 3 years

Revenue for Domes Pharma Group top domains

domespharma.com75M - 100M

See more with Sales Intelligence

Total visits to Domes Pharma Group's top domains

Understand Domes Pharma Group market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

domespharma.com3.7K

See more with Sales Intelligence

Avg. visit duration in Domes Pharma Group's top domains

Analyze Domes Pharma Group engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

domespharma.com00:00:49

See more with Sales Intelligence

Avg. pageviews on Domes Pharma Group's top domains

See how Domes Pharma Group keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

domespharma.com1.71

See more with Sales Intelligence

Domes Pharma Group top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Domes Pharma Group

These are the website technologies, by industry, used by Domes Pharma Group top domains

Payment & Currencies (24)

Cart Functionality

Widget (10)

Twemoji

Advertising (4)

Google Adsense

Email Services (4)

Microsoft Exchange Online

More Technologies

10

See all

News & Signals from Domes Pharma Group

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDÔMES PHARMA Group acquired Sentrxanimalcare on Aug 16th '23.Dômes Pharma announces acquisition of SentrX Animal Care.

NewsDÔMES PHARMA Group partners with EquiCord, SL company.The Dômes Group announces the signature of an exclusive partnership with the biotech company EquiCord to distribute the world´s first stem cell-based drug for the treatment of canine osteoarthritis.

NewsDÔMES PHARMA Group acquires Pronozia.The Dômes Pharma Group announces the acquisition of the Pronozia team and its veterinary decision support technology ZAG®.